106 related articles for article (PubMed ID: 34321624)
1. Downregulation of TMEM220 promotes tumor progression in Hepatocellular Carcinoma.
Li T; Guan L; Tang G; He B; Huang L; Wang J; Li M; Bai Y; Li X; Zhang H
Cancer Gene Ther; 2022 Jun; 29(6):835-844. PubMed ID: 34321624
[TBL] [Abstract][Full Text] [Related]
2. LncRNA TMEM220-AS1 suppresses hepatocellular carcinoma cell proliferation and invasion by regulating the TMEM220/β-catenin axis.
Liu Y; Liu R; Zhao J; Zeng Z; Shi Z; Lu Q; Guo J; Li L; Yao Y; Liu X; Xu Q
J Cancer; 2021; 12(22):6805-6813. PubMed ID: 34659569
[TBL] [Abstract][Full Text] [Related]
3. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
4. AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway.
Kannan M; Jayamohan S; Moorthy RK; Chabattula SC; Ganeshan M; Arockiam AJV
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698701
[TBL] [Abstract][Full Text] [Related]
5. Down-Regulated NRSN2 Promotes Cell Proliferation and Survival Through PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma.
Wang X; Han L; Zhang J; Xia Q
Dig Dis Sci; 2015 Oct; 60(10):3011-8. PubMed ID: 26055238
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation-mediated silencing of Neuronatin promotes hepatocellular carcinoma proliferation through the PI3K-Akt signaling pathway.
Deng Y; Lu L; Liang X; Li J; Zhu D; Huang H; Zhang Y; Zhang X; Chen Y; Liu X; Fu Y
Life Sci; 2023 Jan; 312():121266. PubMed ID: 36473542
[TBL] [Abstract][Full Text] [Related]
7. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-623 suppresses progression of hepatocellular carcinoma via regulating the PI3K/Akt signaling pathway by targeting XRCC5.
Ren F; Su H; Jiang H; Chen Y
J Cell Biochem; 2020 Jan; 121(1):213-223. PubMed ID: 31190447
[TBL] [Abstract][Full Text] [Related]
9. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
[No Abstract] [Full Text] [Related]
10. miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.
Xiao ZD; Jiao CY; Huang HT; He LJ; Zhao JJ; Lu ZY; Liu LX
Int J Clin Exp Pathol; 2014; 7(7):4039-44. PubMed ID: 25120782
[TBL] [Abstract][Full Text] [Related]
11. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.
Du A; Li S; Zhou Y; Disoma C; Liao Y; Zhang Y; Chen Z; Yang Q; Liu P; Liu S; Dong Z; Razzaq A; Tao S; Chen X; Liu Y; Xu L; Zhang Q; Li S; Peng J; Xia Z
Mol Cancer; 2022 May; 21(1):109. PubMed ID: 35524319
[TBL] [Abstract][Full Text] [Related]
12. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
Wu L; Zheng J; Chen P; Liu Q; Yuan Y
Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-148a Inhibits Hepatocellular Carcinoma Cell Growth via Epithelial-to-Mesenchymal Transition and PI3K/AKT Signaling Pathways by Targeting Death Receptor-5.
Zhang N; Zhou J; Zhou Y; Guan F
Appl Biochem Biotechnol; 2022 Jun; 194(6):2731-2746. PubMed ID: 35267120
[TBL] [Abstract][Full Text] [Related]
15. Long Non-coding RNA TMEM220-AS1 Suppressed Hepatocellular Carcinoma by Regulating the miR-484/MAGI1 Axis as a Competing Endogenous RNA.
Cao C; Li J; Li G; Hu G; Deng Z; Huang B; Yang J; Li J; Cao S
Front Cell Dev Biol; 2021; 9():681529. PubMed ID: 34422806
[TBL] [Abstract][Full Text] [Related]
16. Formiminotransferase Cyclodeaminase Suppresses Hepatocellular Carcinoma by Modulating Cell Apoptosis, DNA Damage, and Phosphatidylinositol 3-Kinases (PI3K)/Akt Signaling Pathway.
Chen J; Chen Z; Huang Z; Yu H; Li Y; Huang W
Med Sci Monit; 2019 Jun; 25():4474-4484. PubMed ID: 31203308
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
[TBL] [Abstract][Full Text] [Related]
18. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
Han K; Li C; Zhang X; Shang L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
[TBL] [Abstract][Full Text] [Related]
19. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.
Xie C; Song LB; Wu JH; Li J; Yun JP; Lai JM; Xie DY; Lin BL; Yuan YF; Li M; Gao ZL
PLoS One; 2012; 7(7):e40607. PubMed ID: 22815774
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
